Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone

  • PDF / 1,434,559 Bytes
  • 10 Pages / 595.276 x 790.866 pts Page_size
  • 59 Downloads / 154 Views

DOWNLOAD

REPORT


RESEARCH ARTICLE

Trends in reporting drug‑associated liver injuries in Taiwan: a focus on amiodarone Jun‑Hong Ye1,2 · Yunn‑Fang Ho1,3 · Angela W.‑F. On1,4 · Wen‑Wen Chen4 · Yen‑Ming Huang1 · Wei‑I. Huang4 · Yun‑Wen Tang2 Received: 9 December 2017 / Accepted: 20 July 2018 © Springer Nature Switzerland AG 2018

Abstract Background A pharmacovigilance database of real-world adverse drug reaction (ADR) reports is helpful for characterising adverse events and identifying new signals after drug approval. Objective This study aimed to analyse trends of ADR reporting in relation to liver injury and to delineate critical factors for suspected drug-related hepatotoxicity with a focus on reports associated with amiodarone. Setting The 2000–2014 Taiwan pharmacovigilance database. Method Relevant Standardized Medical Dictionary for Regulatory Activities queries were used to identify reports associated with liver injury. Information on ADR, patient characteristics, and the verbatim pertaining to amiodarone prescriptions, liver injury, comedications, and comorbidities were extracted and evaluated. Group comparisons between Hy’s Law cases and Temple’s Corollary cases of suspected amiodarone-related hepatotoxicity were performed. Main outcome measure Number and nature of drug-related liver injuries, particularly those associated with amiodarone. Results Of the 98,777 ADR reports over a 15-year period, 4261 (4.3%) were related to liver injury. Sixty-eight reports contained amiodarone prescriptions, but only 49 (1.1%) were eligible for further analysis. Hepatotoxic cases associated with amiodarone mostly occurred within 1 week, exhibited a hepatocellular pattern, and were more common among elderly individuals. Among 23 discernible cases, four (17.4%) recovered fully from liver injury. The critical Hy’s Law cases were associated with shorter height, lower body surface area, and higher average daily doses. Conclusion This study substantiates the importance of ADR reporting. Data pertaining to drug-associated liver injury and factors associated with suspected amiodarone-related hepatotoxicity warrants continual attention in pharmacovigilance for those at risk, especially the elderly. Keywords  Adverse drug reactions · Amiodarone · Hepatotoxicity · MedDRA-coded database · Pharmacovigilance · Taiwan

Impacts of practice

• Both drug disposition (adjusted average daily dose) and

• Drug-associated liver injury is not common, but is of

host factors (shorter height and lower BSA) are associated with the risk of amiodarone-related liver injury. • Reporting, archiving, and analysing of real-world adverse drug reactions may facilitate the extraction of knowledge from rare signals.

* Yunn‑Fang Ho [email protected]

Introduction

clinical significance.

1



Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan

2



Present Address: National Taiwan University Hospital, Taipei, Taiwan

3

School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan

4

Taiwan National AD